Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1.
about
Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor.Role of CSF-1 in progression of epithelial ovarian cancerThe detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFβ in claudin-low breast tumor cellsTumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell linesA polymerase chain reaction-based microsatellite typing assay used for tumor cell line identification.Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.Macrophage colony-stimulating factor is expressed by an ovarian carcinoma subline and stimulates the c-myc proto-oncogene.Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme.The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer.Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1.Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor.M2-like macrophage polarization in high lactic acid-producing head and neck cancerEpithelial ovarian cancer: a cytokine propelled disease?Pyrrolo[3,2-c]pyridine derivatives with potential inhibitory effect against FMS kinase: in vitro biological studies
P2860
Q33403766-ADE9289B-206E-4561-873D-98D6B70215BDQ33694369-364E3284-51D0-47B6-8884-54FAEE88F456Q34219670-FEF29F34-2CA0-41C8-A5E8-614160B19C62Q35050162-2C8F87BE-9EEC-487D-8B40-B7683730EF46Q35582297-40825B79-A8BA-4A96-ABDB-6A96CCBF9258Q35764436-19383FA5-9793-4ECC-8FAD-CF89DFAC4E46Q35830913-512BF8D0-4181-4E65-BD7A-9CA869945F83Q35833311-4A770062-924A-4650-A36E-57C5F443A8CDQ35977743-5F725AB2-39A5-4F85-8A1B-0DF633B62743Q36081883-12B5B30C-D842-4A5A-9FD7-35A674E51D2AQ36233022-A47F3EAF-5D9A-4BB0-81C3-CCDA336521D9Q36431222-80BE3DC1-81C9-4D5A-8C36-93A7F4A19357Q36982940-93A0A543-926C-4C05-A1A1-BA783F0DBE38Q36996594-FD359BE4-1CBF-4625-995D-FE7F5D85CCB6Q37362682-3C587297-3DF4-4AF6-B5D1-355538DC555DQ37480291-E256998A-3B4B-42DF-87DB-9F6BDCCA0D38Q41071895-A0EC58C8-8204-4BF4-8F36-A4ACC9EFA52CQ42372220-B1BFFE42-75CD-4748-AFE6-3E8E0B9D2BA0Q58803351-CC12FDFB-2466-471A-951F-3CDE594FBA12
P2860
Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Ovarian adenocarcinomas expres ...... en with coexpression of CSF-1.
@ast
Ovarian adenocarcinomas expres ...... en with coexpression of CSF-1.
@en
type
label
Ovarian adenocarcinomas expres ...... en with coexpression of CSF-1.
@ast
Ovarian adenocarcinomas expres ...... en with coexpression of CSF-1.
@en
prefLabel
Ovarian adenocarcinomas expres ...... en with coexpression of CSF-1.
@ast
Ovarian adenocarcinomas expres ...... en with coexpression of CSF-1.
@en
P2093
P2860
P1476
Ovarian adenocarcinomas expres ...... en with coexpression of CSF-1.
@en
P2093
B M Kacinski
L Donofrio
L R Rohrschneider
S K Chambers
T Yang-Feng
P2860
P304
P407
P577
1990-07-01T00:00:00Z